Metabolic danger signals, uric acid and ATP, mediate inflammatory cross‐talk between hepatocytes and immune cells in alcoholic liver disease

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Leukocyte Biology

• Publication date

  2015-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1189/jlb.3AB1214-590RPMID 25934928PMCID PMC4501673
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hexokinase II binding to mitochondria is necessary for Kupffer cell activation and is potentiated by ethanol exposure.

  2016influential reference
• Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1β in mice.

  2015cited by this paper
• Acute Binge Drinking Increases Serum Endotoxin and Bacterial DNA Levels in Healthy Individuals

  2014cited by this paper
• Hexokinase II Binding to Mitochondria Is Necessary for Kupffer Cell Activation and Is Potentiated by Ethanol Exposure*

  2014cited by this paper
• Alcohol-Induced Liver Injury Is Modulated by Nlrp3 and Nlrc4 Inflammasomes in Mice

  2013cited by this paper
• Alcohol‐induced IL‐1β in the brain is mediated by NLRP3/ASC inflammasome activation that amplifies neuroinflammation

  2013cited by this paper
• IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice.

  2012cited by this paper
• Type I interferons protect from Toll-like receptor 9-associated liver injury and regulate IL-1 receptor antagonist in mice.

  2011cited by this paper
• Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice.

  2011cited by this paper
• Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells

  2011cited by this paper
• Innate immunity in alcoholic liver disease.

  2011cited by this paper
• Initiation of Purinergic Signaling by Exocytosis of ATP-containing Vesicles in Liver Epithelium*

  2010cited by this paper
• Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice.

  2010cited by this paper
• The inflammasomes.

  2010cited by this paper
• NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?

  2010cited by this paper
• The NLRP3 Inflammasome: A Sensor for Metabolic Danger?

  2010cited by this paper
• Immunological and inflammatory functions of the interleukin-1 family.

  2009cited by this paper
• The critical role of toll‐like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88

  2008cited by this paper
• An inducible autocrine cascade regulates rat hepatocyte proliferation and apoptosis responses to tumor necrosis factor‐α

  2008cited by this paper
• Activation of the innate immune system and alcoholic liver disease: effects of ethanol per se or enhanced intestinal translocation of bacterial toxins induced by ethanol?

  2005cited by this paper
• Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation.

  2004cited by this paper
• Molecular identification of a danger signal that alerts the immune system to dying cells

  2003cited by this paper
• Antibiotics prevent liver injury in rats following long-term exposure to ethanol.

  1995cited by this paper
• Inactivation of Kupffer cells prevents early alcohol‐induced liver injury

  1994cited by this paper
• Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: II. IL-1 receptor antagonist inhibits lipopolysaccharide-induced cytokine synthesis by human monocytes.

  1992cited by this paper
• Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: I. IL-1 receptor antagonist inhibits IL-1-induced cytokine synthesis and blocks the binding of IL-1 to its type II receptor on human monocytes.

  1992cited by this paper

• The role of Triglyceride Glucose-Waist Circumference (TyG_WC) in predicting metabolic dysfunction-associated steatotic liver disease among individuals with hyperuricemia

  2025cites this paper
• Life-threatening risk factors contribute to the development of diseases with the highest mortality through the induction of regulated necrotic cell death

  2025influential citation
• NLRP3 Inflammasome Activation in Liver Disorders: From Molecular Pathways to Therapeutic Strategies

  2025cites this paper
• From stress signals to fertility challenges: the role of damage-associated molecular patterns in male reproduction

  2025cites this paper
• Role of Intestinal Microbiome in Potentiating Inflammation and Predicting Outcomes in Alcohol-Associated Cirrhosis.

  2025cites this paper
• Metabolites in the extracellular tumor microenvironment and the shaping of macrophage function.

  2025cites this paper
• IL-1 family of cytokines in gastrointestinal and liver disorders

  2025cites this paper
• Regulated necrosis at the crossroads of liver inflammation and cancer development.

  2025cites this paper
• Oxidative Stress in Liver Metabolic Dysfunction and Diseases, with a Focus on Hepatogenic Diabetes: Effect of Alcohol Consumption

  2025cites this paper
• Mitochondrial dynamics, quality control and mtDNA in Alcohol-associated liver disease and liver cancer.

  2024cites this paper
• The P2Y2 receptor as a sensor of nucleotides and cell recruitment during inflammatory processes of the liver

  2024cites this paper
• NcRNA Regulated Pyroptosis in Liver Diseases and Traditional Chinese Medicine Intervention: A Narrative Review

  2024cites this paper
• Endothelial Dysfunction and Liver Cirrhosis: Unraveling of a Complex Relationship

  2024cites this paper
• 3PM-guided innovation in treatments of severe alcohol-associated hepatitis utilizing fecal microbiota transplantation

  2024cites this paper
• Cholesterol Checking Tool and Blood Type Prototype with Telegram Notification System

  2024cites this paper
• Inflammation and gut microbiota in the alcoholic liver disease

  2024cites this paper
• Pathogenesis of Alcohol-Associated Liver Disease.

  2024cites this paper
• Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation

  2024cites this paper
• Combined Insults of a MASH Diet and Alcohol Binges Activate Intercellular Communication and Neutrophil Recruitment via the NLRP3-IL-1β Axis in the Liver

  2024cites this paper
• Endogenous ethanol production in health and disease

  2024cites this paper
• Neutrophil extracellular traps activate hepatic stellate cells and monocytes via NLRP3 sensing in alcohol-induced acceleration of MASH fibrosis

  2024cites this paper
• Cell Death in Liver Disease and Liver Surgery

  2024cites this paper
• Ethanol causes non-communicable disease through activation of NLRP3 inflammasome: a review on mechanism of action and potential interventions

  2024influential citation
• Pharmacotherapy of Liver Fibrosis and Hepatitis: Recent Advances

  2024cites this paper
• Cell-to-cell and organ-to-organ crosstalk in the pathogenesis of alcohol-associated liver disease

  2024cites this paper
• PTTG1 alleviates acute alcoholic liver injury by inhibiting endoplasmic reticulum stress‐induced hepatocyte pyroptosis

  2023cites this paper
• Advances in the management of alcohol-associated liver disease

  2023cites this paper
• Food-derived peptides as novel therapeutic strategies for NLRP3 inflammasome-related diseases: a systematic review

  2023cites this paper
• Hepatic Macrophages as Targets for the MSC-Based Cell Therapy in Non-Alcoholic Steatohepatitis

  2023cites this paper
• NLRP3 inflammasome in hepatic diseases: A pharmacological target.

  2023cites this paper
• Influence of intestinal microecology in the development of gout or hyperuricemia and the potential therapeutic targets

  2023cites this paper
• NLRP3: a new therapeutic target in alcoholic liver disease

  2023cites this paper
• Drinking and laboratory biomarkers, and nutritional status characterize the clinical presentation of early-stage alcohol-associated liver disease.

  2023cites this paper
• Ginsenoside Rk2, a dehydroprotopanaxadiol saponin, alleviates alcoholic liver disease via regulating NLRP3 and NLRP6 inflammasome signaling pathways in mice

  2023cites this paper
• The role of pyroptosis in inflammatory diseases

  2023cites this paper
• Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review

  2023cites this paper
• Fructose potentiates the protective efficiency of live Edwardsiella tarda cell vaccine

  2023cites this paper
• A Preliminary Study on the Mechanism of Alcohol Abuse in Alzheimer’s Disease

  2023cites this paper
• Alcohol-induced extracellular ASC specks perpetuate liver inflammation and damage in alcohol-associated hepatitis even after alcohol cessation

  2023influential citation
• Alcohol, Inflammation, and Microbiota in Alcoholic Liver Disease

  2023cites this paper
• Ameliorating effects of water bamboo shoot (Zizania latifolia) on acute alcoholism in a mice model and its chemical composition.

  2022cites this paper
• Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease

  2022cites this paper
• Pharmacological effects of Chinese medicine modulating NLRP3 inflammasomes in fatty liver treatment

  2022cites this paper
• Therapeutic Perspectives of IL1 Family Members in Liver Diseases: An Update

  2022cites this paper
• Oral squamous cell carcinoma (OSCC) tumors from heavy alcohol consumers are associated with higher levels of TLR9 and a particular immunophenotype: Impact on patient survival

  2022cites this paper
• Advancements in the Alcohol-Associated Liver Disease Model

  2022cites this paper
• Inflammasomes and Pyroptosis of Liver Cells in Liver Fibrosis

  2022cites this paper
• NLRP3 Inflammasome and Pyroptosis in Liver Pathophysiology: The Emerging Relevance of Nrf2 Inducers

  2022cites this paper
• P2X7 Receptor in Alcoholic Steatohepatitis and Alcoholic Liver Fibrosis

  2022cites this paper
• Diallyl disulfide ameliorates ethanol-induced liver steatosis and inflammation by maintaining the fatty acid catabolism and regulating the gut-liver axis.

  2022cites this paper
• Inhibition of HMGB1/TLR4 Signaling Pathway by Digitoflavone: A Potential Therapeutic Role in Alcohol-Associated Liver Disease.

  2022cites this paper
• Cell-to-Cell Communications in Alcohol-Associated Liver Disease

  2022cites this paper
• Crosstalk between Oxidative Stress and Inflammatory Liver Injury in the Pathogenesis of Alcoholic Liver Disease

  2022cites this paper
• Role of the Inflammasome in Liver Disease.

  2021cites this paper
• Research methodologies to address clinical unmet needs and challenges in alcohol‐associated liver disease

  2021cites this paper
• IMPACT OF ETHANOL INTAKE ON FIBROBLAST GROWTH FACTOR 21 AND BILE ACID METABOLISM

  2021cites this paper
• The Immune System through the Lens of Alcohol Intake and Gut Microbiota

  2021cites this paper
• The Impact of the NLRP3 Pathway in the Pathogenesis of Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease

  2021cites this paper
• The association between serum uric acid and controlled attenuation parameter in United States adults without hepatitis B and C: a cross-sectional study

  2021cites this paper
• Pathogenetic mechanisms of nonalcoholic fatty liver disease and inhibition of the inflammasome as a new therapeutic target.

  2021cites this paper
• Inflammasome as an Effective Platform for Fibrosis Therapy

  2021cites this paper
• The mechanism by which ATP regulates alcoholic steatohepatitis through P2X4 and CD39.

  2021cites this paper
• Efficacy of Thiamine and Medical Management in Treating Hyperuricemia in AUD Patients with ALD: Role of Hyperuricemia in Liver Injury, Gut-Barrier Dysfunction, and Inflammation

  2021cites this paper
• Pyroptosis in steatohepatitis and liver diseases.

  2021cites this paper
• Alcoholic liver disease: Current insights into cellular mechanisms

  2021cites this paper
• Gut microbiome, liver immunology, and liver diseases

  2020cites this paper
• Purine signaling regulating HSCs inflammatory cytokines secretion, activation, and proliferation plays a critical role in alcoholic liver disease

  2020cites this paper
• Macrophage Phenotype and Function in Liver Disorder

  2020cites this paper
• Cellular Interplay as a Consequence of Inflammatory Signals Leading to Liver Fibrosis Development

  2020cites this paper
• Elevated Fructose and Uric Acid Through Aldose Reductase Contribute to Experimental and Human Alcoholic Liver Disease

  2020cites this paper
• Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and Scope

  2020cites this paper
• Paeonol ameliorates murine alcohol liver disease via mycobiota‐mediated Dectin‐1/IL‐1β signaling pathway

  2020cites this paper
• Inhibition of HSP90 and activation of HSF1 diminishes macrophage NLRP3 inflammasome activity in alcoholic liver injury.

  2020cites this paper
• Lytic Cell Death in Metabolic Liver Disease.

  2020cites this paper
• The Effects of Natural Iridoids and Anthocyanins on Selected Parameters of Liver and Cardiovascular System Functions

  2020influential citation
• DANGER SIGNALS IN LIVER INJURY AND RESTORATION OF HOMEOSTASIS.

  2020cites this paper
• The NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis

  2020cites this paper
• Design and rationale of a multicenter defeat alcoholic steatohepatitis trial: (DASH) randomized clinical trial to treat alcohol-associated hepatitis.

  2020cites this paper
• Unveiling Sex-Based Differences in the Effects of Alcohol Abuse: A Comprehensive Functional Meta-Analysis of Transcriptomic Studies

  2020cites this paper
• Programmed cell death in alcohol-associated liver disease

  2020cites this paper
• Progress in inflammasome activation and pyrolysis in alcoholic liver disease.

  2020cites this paper
• Immunopathobiology and therapeutic targets related to cytokines in liver diseases

  2020cites this paper
• Pyroptosis in liver disease.

  2020cites this paper
• Immunological mechanisms and therapeutic targets of fatty liver diseases

  2020cites this paper
• Gentiopicroside prevents alcoholic liver damage by improving mitochondrial dysfunction in the rat model

  2020cites this paper
• The Uniqueness of Innate Immunity

  2020cites this paper
• Cell Death in Liver Diseases: A Review

  2020cites this paper
• Regulation of the NLRP3 inflammasome with natural products against chemical-induced liver injury.

  2020cites this paper
• Solid Organ Injury

  2020cites this paper
• Penthorum Chinense Pursh Protects Liver From Alcohol-induced Steatosis in Zebrafish by Mechanisms Including Inhibition of Oxidative Stress and Increase in Autophagy

  2020cites this paper
• Current trials and novel therapeutic targets for alcoholic hepatitis.

  2019cites this paper
• Netosis as a bridge between inflammation and liver cell injury

  2019cites this paper
• Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting

  2019cites this paper
• Intestinal barrier dysfunction and alcoholic liver disease

  2019cites this paper
• Role of mitochondrial depolarization and disrupted mitochondrial homeostasis in non-alcoholic steatohepatitis and fibrosis in mice.

  2019cites this paper
• High fructose‐induced metabolic changes enhance inflammation in human dendritic cells

  2019cites this paper
• A non-autonomous role of MKL1 in the activation of hepatic stellate cells.

  2019cites this paper
• Regulation of CD39 expression in ATP-P2Y2R-mediated alcoholic liver steatosis and inflammation.

  2019cites this paper
• Pyroptosis in Liver Disease: New Insights into Disease Mechanisms

  2019cites this paper
• Recent Insights Into the Role of Immune Cells in Alcoholic Liver Disease

  2019cites this paper